HL Pharma: Safeguarding the Integrity of Clinical Trial Materials Across Australia
The storage and distribution of clinical trial materials are among the most critical yet complex aspects of modern pharmaceutical research. As investigational medicinal products (IMPs) become increasingly specialised and temperature sensitive, ensuring their integrity from manufacturing to patient administration has become a critical responsibility for sponsors, CROs, and logistics partners. At HL Pharma, we understand that every molecule matters. Our GDP-compliant, ISO 9001:2015-certified facility in Melbourne provides end-to-end support for clinical trial material management from controlled storage and validated packaging to national distribution and track-and-trace logistics.
Precision Storage and Distribution for Sensitive Medicines
No two clinical studies are alike. HL Pharma tailors storage and distribution strategies to the specific needs of each product, patient group, and study design. Whether using a central depot, direct to site model, or hybrid supply chain, our focus is maintaining product stability, compliance, and patient safety at every step.
Our temperature-controlled environments include:
- 2-8°C refrigerated storage
- 15-25°C controlled room temperature (CRT)
- -20°C frozen and -80°C ultra-low storage
- Vaulted Schedule 8 and 9 controlled drug areas with two person access and continuous surveillance
Every consignment is handled with care, using validated cold chain packaging, data logging, and risk assessed transport routes to ensure total traceability from depot to site.
Partnering with Sponsors and CROs for Compliance and Confidence
HL Pharma acts as a seamless extension of our clients clinical teams, working closely with sponsors, contract research organisations (CROs), and contract manufacturers (CMOs) to maintain full regulatory compliance under TGA, Office of Drug Control (ODC), and GDP frameworks. Our qualified supplier network, three stage partner verification, and robust Quality Management System (QMS) ensure every touchpoint in the supply chain meets international standards. From product receipt to controlled destruction, every movement is logged, verified, and accessible via the HL Pharma Client Portal providing real time visibility of stock, batch numbers, expiry dates, and temperature data.
Cold-Chain Management and Real-Time Monitoring
With most IMPs now requiring temperature control, our computerised environmental monitoring system maintains strict conditions 24 hours a day. Real time alerts, integrated warehouse management, and automated reporting allow rapid response to any deviation.
Through continuous data exchange with our clients, HL Pharma enables faster decision making, reduced waste, and lower trial risk ensuring every dose reaches its destination safely and compliantly.
End to End Traceability and Recall Readiness
Our validated track and trace systems provide complete visibility from manufacturer to patient. Whether managing depot stock, site replenishment, or direct-to-patient shipments, every stage is traceable to maintain control, accountability, and recall readiness.
HL Pharma’s systems align with EU GDP and Annex 13 requirements, ensuring quality assurance and regulatory confidence for international partners seeking compliant Australian storage and distribution.
Commitment to Clinical Excellence
As highlighted in the Journal for Clinical Studies, successful clinical trial logistics depend on forward planning, reliable partners, and robust technical systems to manage complexity and ensure patient safety.
At HL Pharma, we combine decades of pharmaceutical experience with advanced infrastructure to deliver precision in pharmaceutical management and storage, supporting sponsors and CROs in navigating Australian clinical supply requirements efficiently and compliantly.
Source: Adapted from Clinical Trial Material Storage and Distribution A Critical Mission, Journal for Clinical Studies, Vol. 7, Issue 4.